Comprehensive Introduction to Blood Type and Screen (T&S)
In the field of transfusion medicine and surgical preparation, few procedures are as foundational as the Blood Type and Screen (T&S). As an orthopedic specialist, I frequently order this diagnostic panel before elective surgeries, such as total joint arthroplasties, to ensure patient safety in the event of an intraoperative hemorrhage.
A Type and Screen is a two-part laboratory procedure designed to identify a patient’s blood group (ABO) and Rh status, while simultaneously screening the serum for the presence of unexpected alloantibodies. Unlike a "Type and Crossmatch," which physically mixes donor blood with patient blood, the "Screen" component identifies the potential for a delayed or acute hemolytic transfusion reaction, allowing for rapid blood procurement if an emergency arises.
Deep-Dive: Technical Specifications and Mechanisms
The T&S procedure is a cornerstone of immunohematology. It relies on the principles of antigen-antibody interactions, specifically hemagglutination.
1. ABO/Rh Typing
This portion of the test determines the patient's ABO blood group (A, B, AB, or O) and Rh factor (Positive or Negative).
* Forward Typing: Uses known anti-A and anti-B reagents to detect A or B antigens on the patient’s red blood cells (RBCs).
* Reverse Typing: Uses known reagent A and B cells to detect anti-A and anti-B antibodies in the patient’s serum.
2. Antibody Screening
The "Screen" portion utilizes a panel of reagent red blood cells that have been phenotyped for a wide array of clinically significant antigens (e.g., Kell, Duffy, Kidd).
* Mechanism: Patient serum is incubated with reagent cells.
* Detection: If the patient has developed antibodies (usually through prior transfusion, pregnancy, or transplantation), those antibodies will bind to the reagent cells, causing agglutination, which is then visualized via a centrifuge or gel column technology.
| Component | Purpose | Clinical Significance |
|---|---|---|
| ABO Typing | Identify A, B, O antigens | Prevents ABO-incompatible transfusion |
| Rh Typing | Identify D-antigen | Prevents Rh-alloimmunization |
| Antibody Screen | Detect unexpected antibodies | Prevents delayed hemolytic reactions |
Extensive Clinical Indications and Usage
The T&S is indicated in any clinical scenario where there is a non-zero probability that a patient may require blood products.
Pre-Surgical Preparation
For orthopedic surgeons, the T&S is standard protocol for:
* Total Hip Arthroplasty (THA)
* Total Knee Arthroplasty (TKA)
* Complex spine reconstruction (e.g., scoliosis correction)
* Revision surgeries with high risk of vascular injury
Obstetrics
Every pregnant patient undergoes a T&S to screen for Rh-incompatibility, which can lead to Hemolytic Disease of the Fetus and Newborn (HDFN).
Trauma and Emergency Medicine
In the acute setting, the T&S allows the blood bank to maintain a record of the patient's phenotype, enabling the rapid release of "type-specific" blood even before a full crossmatch is completed.
Chronic Conditions
Patients with hematologic disorders, such as sickle cell disease or thalassemia, require frequent T&S to monitor for the development of multiple alloantibodies over time.
Specimen Collection and Laboratory Protocols
Accuracy in the T&S begins at the bedside. Strict adherence to patient identification protocols is mandatory to prevent "wrong blood in tube" errors.
Specimen Requirements
- Tube Type: Lavender top (EDTA) or Pink top (EDTA) tubes are standard.
- Labeling: Must include two patient identifiers (Full Name, DOB, MRN).
- Timing: For patients who have been pregnant or transfused in the last 3 months, the sample must be collected within 72 hours of the intended transfusion to ensure the antibody screen remains current.
Interfering Factors
Several factors can lead to false-positive or false-negative results in a T&S:
1. Rouleaux Formation: Caused by high levels of serum proteins (e.g., multiple myeloma), which can mimic agglutination.
2. Recent IV Contrast: Some studies suggest certain dyes can interfere with testing reagents.
3. Cold Agglutinins: Antibodies that react at room temperature can cause false-positive results in the reverse typing.
4. Medications: Drugs like IVIG or certain antibiotics can coat RBCs, leading to a positive Direct Antiglobulin Test (DAT), complicating the screen.
Risks, Side Effects, and Contraindications
The T&S itself is a blood draw procedure and carries minimal risk, primarily limited to:
* Hematoma at the venipuncture site.
* Syncope (fainting) during blood draw.
* Local infection at the site of puncture.
There are no contraindications to performing a T&S. It is a diagnostic safety measure. In fact, failing to perform a T&S prior to high-risk procedures is considered a significant deviation from the standard of care.
Frequently Asked Questions (FAQ)
1. What is the difference between a Type and Screen and a Type and Crossmatch?
A Type and Screen identifies your blood type and checks for antibodies. A Type and Crossmatch takes the next step by physically mixing your blood with donor blood to ensure they are compatible before transfusion.
2. How long does a Type and Screen result last?
Generally, for a patient who has been transfused or pregnant recently, the results are valid for 72 hours. If the patient has not been exposed to foreign blood, some hospitals extend this to 7–14 days.
3. Can I eat or drink before a Type and Screen?
Yes. There are no fasting requirements for this test.
4. What happens if my Antibody Screen is positive?
If the screen is positive, the laboratory must perform an "Antibody Identification" panel. This identifies specifically which antibodies you have, which may require the blood bank to find "antigen-negative" blood units for you in the future.
5. Why is Rh status so important?
Rh status is critical because the D-antigen is highly immunogenic. If an Rh-negative person receives Rh-positive blood, they will likely develop anti-D antibodies, which can cause severe reactions in future transfusions or pregnancy.
6. Does a T&S tell me if I have an infection?
No. The T&S is strictly for blood banking and transfusion compatibility. It does not screen for HIV, Hepatitis, or other infectious diseases.
7. What does it mean if my blood type is "O Negative"?
O-negative is the "Universal Donor." These individuals lack A, B, and Rh antigens, meaning their blood can be given to almost anyone in an emergency.
8. Is this test painful?
It involves a standard blood draw (venipuncture), which usually causes only minor, temporary discomfort similar to any routine lab test.
9. What is "Reverse Typing" in the lab?
Reverse typing confirms the patient's ABO blood type by testing their serum against known A and B cells to see if it reacts as expected.
10. Can medications affect my T&S results?
Yes, certain medications like intravenous immunoglobulin (IVIG) or high-dose penicillin can cause interference. Always inform your physician of all medications you are currently taking.
Conclusion
The Blood Type and Screen (T&S) is far more than a routine laboratory test; it is a critical safety net that allows medical professionals to provide life-saving transfusions with minimal risk. By understanding the mechanisms behind antigen-antibody detection and the importance of precise specimen collection, healthcare providers ensure that patients remain safe during surgeries and medical treatments. If you are preparing for a procedure, ensure your T&S is completed within the required timeframe to avoid unnecessary delays in your care.